# A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease

> **NCT06613698** · PHASE2 · RECRUITING · sponsor: **GlaxoSmithKline** · enrollment: 393 (estimated)

## Conditions studied

- Liver Diseases, Alcoholic

## Interventions

- **DRUG:** GSK4532990
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06613698
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-09-27
- **Primary completion:** 2027-08-02
- **Final completion:** 2028-03-07
- **Target enrollment:** 393 (ESTIMATED)
- **Last updated:** 2026-04-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06613698

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06613698, "A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06613698. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*